Advertisement
News
Advertisement

Interleukin completes clinical study enrollment

Wed, 03/28/2012 - 2:35pm
Mass High Tech: The Journal of New England Technology

Interleukin Genetics Inc. (OTCQB: ILIU) of Waltham and its partner, the University of Michigan School of Dentistry, said they have completed patient enrollment for a clinical study using Interleukin’s PST genetic test, which may predict periodontal disease.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading